Famotidine and Biopsy bone marrow abnormal - a phase IV clinical study of FDA data

Summary:

Biopsy bone marrow abnormal is reported as a side effect among people who take Famotidine (famotidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Alkeran, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Biopsy bone marrow abnormal when taking Famotidine. It is created by eHealthMe based on reports of 81,914 people who have side effects when taking Famotidine from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

What is Biopsy bone marrow abnormal?

Biopsy bone marrow abnormal is found to be associated with 282 drugs and 271 conditions by eHealthMe. Check the latest studies of Biopsy bone marrow abnormal.

On Jul, 14, 2026

81,914 people reported to have side effects when taking Famotidine.
Among them, 14 people (0.02%) have Biopsy bone marrow abnormal.

Could Famotidine cause Biopsy bone marrow abnormal?

Among these 14 people:

How long have people been on Famotidine when they have Biopsy bone marrow abnormal? *

What is the gender of people who have Biopsy bone marrow abnormal when taking Famotidine? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Biopsy bone marrow abnormal when taking Famotidine? *

What are other drugs people take besides Famotidine? *

What are other side effects people have besides Biopsy bone marrow abnormal? *

Diarrhea: 3 people, 21.43%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%
Anaemia (lack of blood): 3 people, 21.43%
Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
Osteomyelitis (infection of bone): 2 people, 14.29%
Drug Hypersensitivity: 2 people, 14.29%
Loose Tooth: 2 people, 14.29%
Lymphocyte Count Increased: 2 people, 14.29%
Bone Disorder: 2 people, 14.29%
Myelosuppression (a decrease in the production of blood cells): 2 people, 14.29%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 28.57%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 2 people, 14.29%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 1 person, 7.14%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 1 person, 7.14%
Pancreatitis (inflammation of pancreas): 1 person, 7.14%
Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 1 person, 7.14%
Constipation: 1 person, 7.14%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and have Biopsy bone marrow abnormal?

- Check whether Biopsy bone marrow abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Famotidine:

Famotidine (83,421 reports)

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (282 drugs)

Browse all the conditions that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (271 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Famotidine) and Famotidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.